Envoy Medical Inc.

NASDAQ: COCH · Real-Time Price · USD
1.45
-0.03 (-2.03%)
At close: Aug 15, 2025, 9:30 AM

Envoy Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
78K 46K 42K 56K 68K 59K 95K 80K 63K 78K 20K 57K 59K 101K n/a n/a n/a n/a
Cost of Revenue
234K 226K 157K 187K 245K 153K 282K 189K 162K 175K 610K 106K 218K 213K n/a n/a n/a n/a
Gross Profit
-156K -180K -115K -131K -177K -94K -187K -109K -270K -97K -590K -49K -159K -112K n/a n/a n/a n/a
Operating Income
-5.07M -5.11M -4.52M -4.97M -4.86M -4.9M -6.74M -3.38M -4.48M -3.77M -2.91M -1.8M -2.19M -1.49M -964K -2.99M -1.07M -966K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.47K 15.38K 7.84K
Pretax Income
-5.69M -5M -4.62M -5.96M -3.95M -6.27M -4.88M 1.56M -13.25M -13.25M -11.48M -1.34M -1.24M 12.46M -4.72M 5.57M 371.14K -1.47M
Net Income
-5.69M -5M -4.62M -5.96M -3.95M -6.27M -4.88M 1.56M -13.25M -13.25M -11.48M -1.34M -1.24M 12.46M -4.72M 5.57M 371.14K -1.47M
Selling & General & Admin
2.43M 2.18M 1.94M 2.09M 2.09M 2.44M 3.53M 1.43M 2.23M 1.75M 1.33M 812K 674K 1.49M 963.9K 2.99M 1.07M 966.28K
Research & Development
2.48M 2.75M 2.47M 2.76M 2.59M 2.36M 3.06M 1.85M 2.15M 1.93M 1.44M 935K 1.36M 1.05M n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a -36K n/a -8.77M -9.48M -8.57M n/a n/a -1.49M n/a n/a n/a n/a
Operating Expenses
4.91M 4.93M 4.41M 4.84M 4.68M 4.8M 6.55M 3.28M 4.38M 2.49M 2.32M 1.75M 2.04M 1.49M 963.9K 2.99M 1.07M 966.28K
Interest Expense
624K 495K 384K 264K 132K 36K n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.47K n/a n/a
Selling & Marketing Expenses
361K 358K 518K 394K 497K 325K 513K 399K 383K 371K n/a n/a n/a 837K n/a n/a n/a n/a
Cost & Expenses
5.15M 5.15M 4.57M 5.03M 4.93M 4.96M 6.83M 3.46M 4.54M 2.49M 2.93M 1.85M 2.25M 1.91M 963.9K 2.99M 1.07M 966.28K
Income Tax Expense
n/a n/a n/a n/a n/a -9.28K n/a n/a 121.25K n/a n/a n/a n/a 13.95M n/a -54K n/a n/a
Shares Outstanding (Basic)
21.38M 21.33M 21.33M 19.62M 19.6M 18.6M 19.6M 19.55M 19.55M 42.52M 53.13M 10.21M 53.13M 53.13M 53.13M 53.13M 53.13M 42M
Shares Outstanding (Diluted)
19.6M 21.33M 21.33M 19.62M 19.6M 18.6M 19.6M 19.55M 19.55M 42.52M 53.13M 11.21M 53.13M 53.13M 53.13M 53.13M 53.13M 42M
EPS (Basic)
-0.32 -0.29 -0.36 -0.37 -0.27 -0.41 -0.25 0.07 -0.68 -1.3 -0.22 -0.13 -0.17 0.23 -0.09 0.10 0.01 -0.04
EPS (Diluted)
-0.32 -0.29 -0.36 -0.37 -0.27 -0.41 -0.25 0.07 -0.68 -1.3 -0.22 -0.12 -0.15 0.23 -0.09 0.10 0.01 -0.04
EBITDA
-4.98M -4.44M -4.19M -5.65M -3.77M -6.2M -6.69M 1.59M -4.48M -2.49M -2.88M -1.77M -2.18M -1.8M -4.72M 5.57M 371.14K -1.47M
EBIT
-5.07M -4.5M -4.23M -5.7M -3.81M -6.23M -6.74M 1.56M -13.25M -13.25M -2.91M -1.8M -2.19M -1.81M -4.72M 5.57M 371.14K -1.47M
Depreciation & Amortization
85K 61K 48K 49K 42K 34K 48K 29K 29K 27K 26K 22K 14K 13K 499.7K 8.56M 1.44M -504K